Know Cancer

or
forgot password

    • cancer clinical trials in nashville, TN

    • Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Head and Neck Cancer, Precancerous Condition
    Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
    1200.71.1002 Boehringer Ingelheim Investigational Site
    Nashville, Tennessee
    Carcinoma, Non-Small-Cell Lung
    An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia, Multiple Myeloma
    Study of Effects of L-Arginine in Colitis and Colon Cancer
    Vanderbilt Hospital
    Nashville, Tennessee 37232
    Ulcerative Colitis, Colon Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Ovarian Cancer
    Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Unspecified Adult Solid Tumor, Protocol Specific
    Personalized Prevention of Colorectal Cancer Trial
    Vanderbilt Medical Center
    Nashville, Tennessee 37232-2765
    Colorectal Cancer
    Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
    SCRI

    Trial Locations
    SCRI
    The Vanderbilt Clinic, Henry-Joyce Cancer Center
    Advanced Non-clear Cell Renal Cell Carcinoma
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    Sarah Cannon Blood & Marrow Transplant Program
    Nashville, Tennessee 37203
    Multiple Myeloma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Peripheral T-cell Lymphoma
    Everolimus Versus Placebo in Head and Neck Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Head and Neck Cancer
    Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Tennessee Oncology
    Nashville, Tennessee 37203
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Tracking Renal Tumors After Cryoablation Evaluation
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Kidney Neoplasms
    Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia

    Nashville, Tennessee 37203-1632
    Relapsed Multiple Myeloma, Refractory Multiple Myeloma, Waldenstrom Macroglobulinemia
    Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
    Site Reference ID/Investigator# 24983
    Nashville, Tennessee 37232-6307
    Gastric Cancer
    Phase 1 Study of ONX 0912 Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Advanced Solid Tumors
    Validation of a Multi-gene Test for Lung Cancer Risk
    Vanderbilt

    Trial Locations
    Vanderbilt
    Tennessee Valley Veterans Admin.
    Lung Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    ZOSTAVAX® in Renal Transplant Patients
    Vanderbilt University - Medicine - Infectious Diseases
    Nashville, Tennessee 37232-2035
    Herpes Zoster
    Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Non-small Cell Lung Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Leukemia
    Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma
    Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
    Vanderbilt University Medical Center, Div. of Medical Oncology
    Nashville, Tennessee 37232
    Pancreatic Adenocarcinoma
    Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Acute Myeloid Leukemia (AML)
    Safety Study of MGAH22 in HER2-positive Carcinomas
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Breast Cancer, Gastric Cancer, Bladder Cancer, Ovarian Cancer, Non-small Cell Lung Cancer
    RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Sarah Cannon Cancer Center at Centennial Medical Center

    Trial Locations
    Sarah Cannon Cancer Center at Centennial Medical Center
    Tennessee Oncology, PLLC at Sarah Cannon Cancer Center
    Colorectal Cancer
    Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
    Novartis Investigative site
    Nashville, Tennessee 37232
    Neoplasm, Cancer, Tumors
    Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Bladder Cancer Requiring Cystectomy
    Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
    Vanderbilt University Medical Center, Department of Urologic Surgery
    Nashville, Tennessee 37232-2765
    Bladder Cancer
    A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer, Brain Metastases
    Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
    Sarah Cannon Research Institute (SCRI)
    Nashville, Tennessee 37203
    Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Neuroendocrine Tumors of Non-Pancreatic Origin, Hormone Receptor-Positive Breast Cancer
    The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
    Vanderbilt Ingram Cancer Center
    Nashville, Tennessee 37232
    Head and Neck Neoplasms, Fibrosis, Lymphedema, Cytokines, Polymorphism, Genetic, Depression
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Henry-Joyce Cancer Clinic
    Nashville, Tennessee 37232-5536
    Leukemia, Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia
    Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Obstructive Jaundice, Pancreatic Cancer